NVU — Nanoveu Income Statement
0.000.00%
- AU$19.80m
- AU$19.39m
- AU$0.01m
Annual income statement for Nanoveu, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.368 | 0.781 | 0.16 | 0.103 | 0.007 |
Cost of Revenue | |||||
Gross Profit | 0.128 | 0.387 | 0.072 | 0.025 | 0.011 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.09 | 2.8 | 2.66 | 2.25 | 2.85 |
Operating Profit | -1.72 | -2.02 | -2.5 | -2.15 | -2.85 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.76 | -2.32 | -2.67 | -2.16 | -2.85 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.76 | -2.32 | -2.67 | -2.16 | -2.85 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1.76 | -2.32 | -2.67 | -2.16 | -2.81 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.76 | -2.32 | -2.67 | -2.16 | -2.81 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.013 | -0.013 | -0.012 | -0.006 | -0.006 |